Immunotherapy drug pembrolizumab shows promise for patients with … – Oncology Nurse Advisor
|
Immunotherapy drug pembrolizumab shows promise for patients with …
Oncology Nurse Advisor The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76{9c067c25ed205f086ce6001901eb13dfadc688a7aefab9f64e0c55b8c5a55872} of patients with pleural mesothelioma. These new study results were presented at the 2015 American Association for Cancer Research (AACR) … |
SOURCE: Mesothelioma – Google News – Read entire story here.
Related posts:
Five Nursing Students Killed, Three Others Injured After 18-Wheeler Fails To Reportedly Slow Down
‘Unprecedented’ Disease Control in Mesothelioma Trial – Medscape
Diagnosed Victims in the Lone Star State: Call the Texas Mesothelioma Victim … – PR Newswire (press release)
Powerful Skin Cancer Drug Stops Mesothelioma Tumor Growth – Asbestos.com
